Metastatic HER2 Negative Breast Carcinoma
Also known as: Her2-negative Metastatic Breast Cancer / HER2 Negative Metastatic Breast Cancer / Metastatic Breast Cancer ( HER2 Negative)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12565 | Abexinostat | 1 | Withdrawn | 1 |
| DB11595 | Atezolizumab | 1 | Completed | 1 |
| DB00958 | Carboplatin | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Completed | 1 |
| DB01248 | Docetaxel | 1 | Completed | 1 |
| DB00997 | Doxorubicin | 1 | Completed | 1 |
| DB11714 | Durvalumab | 1 | Completed | 1 |
| DB08871 | Eribulin | 1 | Completed | 1 |
| DB00947 | Fulvestrant | 1 | Withdrawn | 1 |
| DB11793 | Niraparib | 1 | Completed | 1 |
| DB09073 | Palbociclib | 1 | Withdrawn | 1 |
| DB06592 | Pegargiminase | 1 | Completed | 1 |
| DB06366 | Pertuzumab | 1 | Completed | 1 |
| DB00072 | Trastuzumab | 1 | Completed | 1 |
| DB05773 | Trastuzumab emtansine | 1 | Completed | 1 |
| DB01101 | Capecitabine | 1 / 2 | Recruiting | 1 |
| DB06772 | Cabazitaxel | 2 | Recruiting | 1 |
| DB08871 | Eribulin | 2 | Completed | 1 |
| DB01590 | Everolimus | 2 | Completed | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB12893 | Sacituzumab govitecan | 2 | Recruiting | 1 |
| DB00361 | Vinorelbine | 2 | Completed | 1 |
| DB01259 | Lapatinib | 3 | Completed | 1 |
| DB12001 | Abemaciclib | 4 | Recruiting | 1 |
| DB00947 | Fulvestrant | 4 | Recruiting | 1 |